Nuclear medicine has come a long way since Henri Becquerel first observed the penetrating energy of radioactive materials in 1896. Today, technetium-99m alone is used in more than 40 million diagnostic procedures every year—from cardiovascular imaging and bone scans to cancer detection—making it the undisputed workhorse of nuclear medicine. That single statistic tells you something important: An enormous portion of modern diagnostic medicine rests on a surprisingly narrow foundation, one built around a small number of aging research reactors that were never originally designed for continuous isotope production.

Belgium-based engineering firm Tractebel and the Netherlands’ NRG Pallas have signed a memorandum of understanding to provide engineering services in support of new reactor construction at the Borssele nuclear power plant, located near the village of Borssele in the Dutch province of Zeeland.